Press releases, Reports & Disclosures for Gulf Medical Projects Company

Gulf Medical Projects Company, a public shareholding company, has released its condensed consolidated interim financial statements for the nine-month period ending on September 30, 2024.

The text refers to the condensed consolidated interim financial statements of Gulf Medical Projects Company, a public shareholding company, for the nine-month period ending on September 30, 2024.

Resolution No. 496 of 2024 involves the temporary suspension of trading for Gulf Medical Projects Company shares on the Abu Dhabi Securities Exchange (ADX). This suspension will begin at 12:00 on November 7, 2024, to coincide with the company's Board of Directors meeting, and will continue until ADX receives the meeting's results. The resolution mandates that all department heads at ADX implement this decision within their respective areas. It also requires the resolution to be circulated to the Securities and Commodities Authority (SCA), the concerned company, all ADX departments, and all ADX-accredited brokers. The resolution has been approved by the authorized person and was issued on November 4, 2024.

Gulf Medical Projects Company, a public shareholding company, has released its condensed consolidated interim financial statements for the six-month period ending June 30, 2024.

Gulf Medical Projects Company, a public shareholding company, has released its condensed consolidated interim financial statements for the six-month period ending on June 30, 2024.